Jeremiah Afolabi, PhD, DVM, is a T32 Fellow in the Department of Medicine at Vanderbilt University Medical Center. He holds DVM and MVSc degrees from the University of Ibadan, Nigeria, and a PhD in Molecular and Translational Physiology, with a concentration in renal physiology, from the University of Tennessee Health Science Center.
During his graduate studies, he developed expertise in translational porcine and rodent models, utilizing non-invasive and surgical techniques to study acute kidney injury. He showed that ECE-1-driven ET-1 production and downstream activation of TRPC3-dependent renal vasoconstriction contribute to rhabdomyolysis-induced AKI, leading to first-author publications in high-impact journals and recognition through an American Heart Association predoctoral fellowship.
Dr. Afolabi's current research investigates how excessive sodium triggers myeloid-specific endoplasmic reticulum stress, leading to salt-sensitive hypertension. He also investigates factors driving sex-specific differences in salt sensitivity of blood pressure. Jeremiah’s long-term research interests integrate vascular biology, immunology, functional genomics, and translational physiology to address fundamental questions about hypertension and related cardiovascular diseases.